Syn, Nicholas L; Teng, Michele W L; Mok, Tony S K; Soo, Ross A «De-novo and acquired resistance to immune checkpoint targeting» (en anglès). The Lancet Oncology, 18, 12, 2017, pàg. e731–e741. DOI: 10.1016/s1470-2045(17)30607-1. PMID: 29208439.
«Non-invasive interventions for improving well-being and quality of life in patients with lung cancer». The Cochrane Database of Systematic Reviews, 9, 9-2011, pàg. CD004282. DOI: 10.1002/14651858.CD004282.pub3. PMC: 7197367. PMID: 21901689.
«Non-invasive interventions for improving well-being and quality of life in patients with lung cancer». The Cochrane Database of Systematic Reviews, 9, 9-2011, pàg. CD004282. DOI: 10.1002/14651858.CD004282.pub3. PMC: 7197367. PMID: 21901689.
Prince-Paul M «When hospice is the best option: an opportunity to redefine goals». Oncology (Williston Park, N.Y.), 23, 4 Suppl Nurse Ed, 4-2009, pàg. 13–7. PMID: 19856592.
Syn, Nicholas L; Teng, Michele W L; Mok, Tony S K; Soo, Ross A «De-novo and acquired resistance to immune checkpoint targeting» (en anglès). The Lancet Oncology, 18, 12, 2017, pàg. e731–e741. DOI: 10.1016/s1470-2045(17)30607-1. PMID: 29208439.
«Non-invasive interventions for improving well-being and quality of life in patients with lung cancer». The Cochrane Database of Systematic Reviews, 9, 9-2011, pàg. CD004282. DOI: 10.1002/14651858.CD004282.pub3. PMC: 7197367. PMID: 21901689.
«Non-invasive interventions for improving well-being and quality of life in patients with lung cancer». The Cochrane Database of Systematic Reviews, 9, 9-2011, pàg. CD004282. DOI: 10.1002/14651858.CD004282.pub3. PMC: 7197367. PMID: 21901689.